Well geez mate, though you can give us a head start if you have already done the math....
Sure, I'll find it and post here if you don't want to share.
All I'm saying is that ultimately the performance will determine if the product was acquired for cheap or expensive.
It is doesn't perform at all well then it's expensive no matter what you paid for it....
Austria? Is another pharma selling it there? haha Richards problably don't yes!
Time will tell on how well our gNuvaring ( Myring ) will fare..... I mean if you have a reasonable theory based on other markets.... please share. To say that we will drop to price to cost is not a reasonable theory....why even sell it then.
How does Fornieri feature in your mind?
Either the purchases and execution makes economic sense or they don't. I'm not aware of any legal liability that involved Mayne.
MYX Price at posting:
32.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)